Value of Bacterial Lysates in Prevention of Acute Respiratory Infections in Children
Journal Title: Здоров`я дитини - Year 2013, Vol 5, Issue 48
Abstract
The problem of acute respiratory infectious and inflammatory diseases in children is considered in the article. The functions of nonspecific defense system are described, and there is also given a detailed description of drugs used for the pathogenic treatment of respiratory infections — immunotropic agents of bacterial lysates, particularly Broncho-munal®.
Authors and Affiliations
A. Ye. Abaturov
Keywords
Related Articles
- EP ID EP235998
- DOI -
- Views 85
- Downloads 0
Estimation of Trace Elements (Iodine and Iron) Content in Breast Milk
The estimation of iodine and iron content in breast milk (n = 88) has been carried out. The study shows that the concentration of iodine and iron in breast milk of the women did not correspond to the physiological needs...
Development of the immune response in pneumonia due to Staphylococcus aureus (part 5)
The article on the basis of the literature demonstrated the role of cellular reactions in the development of the immune response in pneumonia caused by Staphylococcus aureus. The mechanisms of interaction of Staphylococc...
The Efficiency of Lactobacillus Rhamnosus GG Probiotic in Complex Treatment of Food Allergy at the Background of Pancreas Pathology in Young Children
In recent years the prevalence of food allergy in children of younger age has become increasingly widespread. For today, secondary pancreatic insufficiency manifested by relative pancreatic insufficiency, is the second l...
Present and future etiological treatment of bacterial pneumonia 3. The antibacterial drugs under development
The rapid spread of antibiotic-resistant bacterial strains necessitates the development of new antibacterial agents and a review of the guidelines for etiological treatment of bacterial infections, including pneumonia. C...
Prognosis criteria of gastroesophageal reflux disease treatment efficacy in school-age children
The important aspect of improving the treatment of children with gastroesophageal reflux disease (GERD) is its individualization. It is impossible without the development of predictors of the treatment efficacy. Outpatie...